Intracavernosal injection of botulinum neurotoxin (BoCox)

Intracavernosal injection of botulinum neurotoxin type A (BoCox) is a minimally invasive procedure for patients with erectile dysfunction, especially when standard therapy is insufficiently effective. The method is innovative and requires individual evaluation by a urologist.

The substance acts on the smooth muscle of the corpora cavernosa, reducing tone and improving blood flow, which can enhance erectile response. The effect is achieved through interaction with the key anatomical components of erection: corpora cavernosa, smooth muscle, and the autonomic nervous system. This approach allows therapeutic application in cases of refractory erectile dysfunction.

Indications

• Erectile dysfunction with insufficient response to PDE-5 inhibitors
• Refractory erectile dysfunction
• Selected cases of organic erectile dysfunction (including vascular)
• Individual decision of the urologist

Procedure

The procedure is performed under sterile conditions with local anesthesia. The substance is injected directly into the corpora cavernosa. Hospitalization is usually not required.

Contraindications

• Active infections
• Allergy to the substance
• Neuromuscular disorders
• Individual evaluation of drug interactions

Recovery / limitations

Usually no restrictions are required after the procedure, and the patient can resume normal activities. The physician may provide individual recommendations depending on the patient’s condition.

Advantages

• Minimally invasive method
• Suitable for refractory erectile dysfunction
• Improves blood flow and erectile response
• Outpatient procedure without need for hospitalization